Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Solid Biosciences Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 58 | 1 | 35 | −22 |
| SharesConverted for a 1-for-15 split | 4.24M | 6 | 15.3M | +11.1M (+261.5%) |
| Value | $33.4M | $0 | $85.6M | +$52.2M (+156.4%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Solid Biosciences Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Camber Capital Management LP | 1,418,439 | $7.63M | 0.27% |
| Caas Capital Management LP | 283,687 | $4.81M | 0.93% |
| Finepoint Capital LP | 218,562 | $1.18M | 0.38% |
| Dimensional Fund Advisors LP | 55,738 | $300.0K | 0.00% |
| Old Well Partners, LLC | 10,800 | $58.1K | 0.05% |
| Belpointe Asset Management LLC | 1,367 | $7.35K | 0.00% |
| Manchester Capital Management LLC | 1,000 | $5.38K | 0.00% |
Sold out (29)
Institutions that held Solid Biosciences Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (1)
Institutions that held Solid Biosciences Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Corsicana & Co. | 90 | – |